Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer
Clinical trial NCT04421222 · TERMINATED
Trial details
- NCT number
- NCT04421222
- Sponsor
- ESSA Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-23
- Primary completion
- 2024-10-31
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.